Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study compared the safety and efficacy of combination therapy with adalimumab plus
methotrexate (MTX) to that of MTX monotherapy (i.e., placebo plus MTX) in subjects with early
rheumatoid arthritis (RA).